Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Clinical trial NCT01672866 · TERMINATED
Trial details
- NCT number
- NCT01672866
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-05
- Primary completion
- 2016-08-02
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.